Kidney and Urology Flashcards
Recommended duration of antibiotic treatment for acute prostatitis?
14 days and then review-may stop at 14 days or continue for a further 14 days.
1st line antibiotic treatment for acute prostatitis?
ciprofloxacin 500mg BD or ofloxacin 200mg BD, if unsuitable the trimethoprim 200mg BD.
Recommended further treatment post TURBT for bladder carcinoma in situ?
intra vesical BCG to improve local control (high risk of becoming muscle invasive) and reduce incidence of progression.
What is Prehn sign?
relief of pain with elevation of testes
positive in epididymo-orchitis
Pharmacological tx of epididymo-orchitis if you suspect STI cause?
IM 1g Ceftriaxone STAT + doxycycline 100mg PO BD for 10-14/7
OR PO ofloxacin 200mg BD for 14/7
if thought to be due to chalmydia or other non gonococcal cause treat with doxycycline or ofloxacin
Pharmacological tx of epididymo-orchitis if you suspect UTI cause/enteric organism?
Ofloxacin 200mg PO BD for 14/7 OR
Levofloxacin 500mg PO OD for 10/7
if quinolone CI e.g. due to hx of seizures or tendon disorders, then tx with co-amoxiclav 500/125 TDS for 10/7
if UTI is confirmed as cause patient should be r/f to urology for investigation for underlying structural abnormality or urinary tract obstruction
How is eGFRcystatinC used to help reduce over diagnosis in early CKD?
Use at initial diagnosis if eGFR is 45-59, sustained for at least 90 days, and no proteinuria (ACR<3) or other marker of kidney disease.
CKD should not be diagnosed if eGFR as as above and eGFRcystatinC >60 and no other marker of kidney disease.
Which patients with CKD require referral for specialist assessment?
- eGFR<30 (stage 4 or 5)
- ACR 70 or more (unless known to be caused by DM and already appropriately treated)
- ACR 30 or more with haematuria
- accelerated progression-sustained decrease in GFR of 25% or more and change in GFR category or sustained decrease of 15ml/min or more within 1 yr-note progression is assessed by repeating eGFR 3 times over at least 3 months
- known/suspected genetic or rare cause
- HTN poorly controlled despite at least 4 anti-HTN drugs at therapeutic doses
- suspected renal artery stenosis
- suspected complication of CKD e.g. renal disease, renal mineral and bone disorder
Target BP in those with CKD?
<140/90
if also diabetic aim <130/80
also if ACR 70 or more aim <130/80
Use of ACEIs/AngII blockers for BP control in patients with CKD?
Offer if:
- diabetic and ACR 3 or more
- HTN and ACR of 30 or more
- ACR 70 or more
do not routinely offer if pre treatment potassium >5
Change in eGFR and creatinine that should prompt stopping of ACEI?
if eGFR change 25% or more, or change in serum creatinine 30% or more, and no other cause for renal deterioration found
if changes less than this rpt U+Es in 1-2 weeks
When should patients with CKD have calcium, phosphate and PTH levels monitored?
if eGFR<30
2ww referral criteria to urology for suspected bladder Ca for patients with visible haematuria?
aged 45 and over with unexplained visible haematuria without UTI or visible haematuria that persists or recurs after successful tx of UTI
(also same criteria as 2ww referral for renal cancer)
2ww referral criteria to urology for suspected bladder Ca for patients with non visible haematuria?
aged 60 and over with unexplained non visible haematuria and either dysuria or raised WCC on blood test
non-urgent referral if aged 60 or over with recurrent or persistent unexplained UTI
Which men should get a PSA and DRE to assess for prostate cancer?
- any lower urinary tract sx e.g. nocturia, urinary frequency, hesitancy, urgency or retention OR
- visible haematuria OR
- erectile dysfunction
2ww referral criteria for penile Ca?
penile ulcerated lesion/mass, where STI has been excluded as cause OR persistent penile lesion after tx for STI completed
1st choice PO Abx for pyelonephritis?
cefalexin
could consider co-amoxiclav or trimethroprim if culture results available and sensitive
if needs IV Abx 1st line=co-amoxiclav, cefuroxime if pregnant
How is risk stratified in localised prostate cancer?
Based on PSA, Gleason score and staging:
low risk-PSA <10 and gleason 6 or less and stage T1-2a
intermediate-PSA 10-20 OR gleason 7 OR stage T2b
high (locally advanced prostate Ca)-PSA >20 PR gleason 8-10 OR stage T2c or more
Gleason score (2-10)=sum of gleason grade (1-5) of the 1st and 2nd most common tumour patterns.
Tx for low risk localised prostate cancer?
active surveillance OR watchful waiting OR radical prostatectomy OR radical radiotherapy (note small increased risk of colorectal cancer)
each tx no difference in mortality from prostate cancer BUT disease progression more likely with active surveillance
urinary continence problems and ED more likely if radical prostatectomy, short term bowel problems more likely with radiotherapy
Tx for intermediate or high risk localised prostate cancer?
offer radical prostatectomy or radical radiotherapy, consider active surveillance if person chooses not to have immediate radical tx if intermediate risk (watchful waiting also an option for any risk group)
if radical radiotherapy for intermediate or high risk localised also offer 6 months of androgen deprivation therapy
How often should PSA be measured in patients with localised prostate cancer who are having radical treatment?
no earlier than 6 weeks after tx
at least every 6 months for the 1st 2 years then at least once a year
Tests if patient with localised prostate cancer chooses active surveillance?
in 1st year, check PSA every 3-4 months, DRE at 1 year and MRI at 12-18 months
after 1 years check PSA every 3-6 months and DRE every 6-12 months for 3 years then PSA every 6 months and DRE every 12 months.
*in contrast to watchful waiting-pt has repeat clinical assessments and PSA testing at least annually but no DRE/MRI
When is a 2ww referral required for a man aged 50-69 who has had a PSA test?
if PSA 3 or higher
note PSA sample must reach the lab within 16 hours
Most common type of testicular cancer?
germ cell tumours
types: seminoma-peak 35 years and non seminomas e.g. teratoma-peak 25 years
How are varicoceles classified?
graded I-III
I=only palpable during valsalva
II=palpable with or without valsalva
III-visualised aswell as easily palpable